Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gulf Biotech is an R&D-driven specialty pharmaceutical manufacturer based in Bahrain, with a focus on sterile injectable formulations. It has launched several first-to-market FDA-approved specialty generics for cardiac patients and maintains a robust pipeline across multiple therapeutic areas. The company operates the only sterile fill-and-finish facility for biopharmaceuticals in Bahrain, offering contract manufacturing services for vials, ampoules, pre-filled syringes, and cartridges. Clinical results per se are not disclosed as the focus is on generics/specialty drugs rather than novel therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gulf Biotech.